Alkem Taloja CRO Facility Clears US FDA Inspection

Alkem Laboratories reports an unannounced US FDA inspection at its Taloja, Maharashtra CRO facility on May 8, 2026.
The inspection concluded without the issuance of any Form 483 observations by the US FDA.
The disclosure is a regulatory filing made to the National Stock Exchange and BSE Limited.